Overall, Gal3 emerges as an important regulator of the immune response, both peripheral and central, and that inhibition of Gal3 may be a potential pharmacological approach to counteract diseases with an inflammatory base, such as PD. The gene discussed is LGALS3; the disease is Parkinson disease.